David A Hall

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Recombinant Human

Angiotensin Converting Enzyme

Respiratory Failure

Intensive Care Unit

Top Venues

Journal of clinical medicine

British journal of pharmacology

Pulmonary therapy

GlaxoSmithKline

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Dec 6o 1996

United Kingdom

GSK Fellow, Scientific Leader :: PVI DPU

Publications

Armand Mekontso Dessap, Kate Hanrott, William M Powley, Andrew Fowler, Andrew Bayliffe, François Bagate, David A Hall, Aili L Lazaar, David C Budd, Antoine Vieillard-Baron
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients. Journal of clinical medicine 11 (15) (2022)
David A Hall, Kate Hanrott, Philipp Badorrek, Dominik Berliner, David C Budd, Rhena Eames, William M Powley, Deborah Hewens, Sarah Siederer, Aili L Lazaar, Anthony Cahn, Jens M Hohlfeld
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study. Pulmonary therapy 7 (2) (2021)
David A Hall, Jesus Giraldo
A method for the quantification of biased signalling at constitutively active receptors. British journal of pharmacology 175 (11) (2018)